Yes, but not just any of them. Two strains of probiotics are recommended in infant colic with a level of evidence based on concordant randomized trials: Lactobacillus reuteri DSM 17938 and Bifidobacterium lactis BB-12 (which we find respectively in the food supplements Biogaia and Calmosine Clq, for example). These strains, administered at the rate of 10⁸ colony-forming unit (CFU) per day over a period of at least 21 days for lactobacillus and at least 21 to 28 days for bifidobacteria, decrease the duration of crying and/or agitation, more particularly in breastfed infants. Their benefit in infant -fed infants seems less clear. Infants colic are defined in particular by recurring and prolonged periods of crying with agitation or irritability of a baby under 5 months, without obvious cause or identified pathology (such as reflux, for example) and cannot be avoided or resolved by parents. Complex, the physiopathology of the disorder can be multifactorial, but it is established that microbiota modifications come into play. Infants with colic have greater digestive abundance of bacteria producing gas by lactose fermentation, carbon hydrates and proteins (like They exhibited chill or gender bacteria Klebsiella) in relation to infants without colic. Some of these bacterial strains can also induce low -grade intestinal inflammation. Bifidobacteria and lactobacilli are, on the other hand, present at least.
Sources: “World Gastroenterology Global Guidelines: Probiotics and Prebiotics”, February 2023; “Infant colic”, sheets of recommendations or information from the French-speaking hepatology-gastroenterology group and pediatric nutrition.
